Advertisement
U.S. Markets closed

ZyVersa Therapeutics, Inc. (ZVSA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.5400-1.0000 (-39.37%)
At close: 04:00PM EST
1.5000 -0.04 (-2.60%)
After hours: 07:44PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Operating Expense
10,424
14,421
13,013
7,704
11,833
Operating Income
-10,424
-14,421
-13,013
-7,704
-11,833
Net Non Operating Interest Income Expense
-582.537
0.457
-427.542
-821.366
-516.45
Other Income Expense
-408.4
-93,333
-607.001
441.581
-333.658
Pretax Income
-11,414
-107,754
-14,048
-8,084
-12,683
Tax Provision
-586.846
-9,456
0
0
-
Net Income Common Stockholders
-21,430
-106,246
-24,063
-8,084
-12,683
Diluted NI Available to Com Stockholders
-21,430
-106,246
-24,063
-8,084
-12,683
Basic EPS
-78.43
-1.09k
-346.10
-139.88
-183.27
Diluted EPS
-78.43
-1.09k
-346.10
-139.88
-183.27
Basic Average Shares
1,243
97.503
69.205
57.792
69.205
Diluted Average Shares
1,243
97.503
69.205
57.792
69.205
Total Operating Income as Reported
-10,424
-107,754
-13,013
-7,704
-11,833
Total Expenses
10,424
14,421
13,013
7,704
11,833
Net Income from Continuing & Discontinued Operation
-11,414
-98,298
-14,048
-8,084
-12,683
Normalized Income
-11,006
-13,178
-13,441
-8,526
-12,350
Interest Income
-
0.457
-
-
-
Interest Expense
582.537
-
427.542
821.366
516.45
Net Interest Income
-582.537
0.457
-427.542
-821.366
-516.45
EBIT
-10,832
-14,421
-13,620
-7,263
-12,167
EBITDA
-10,822
-14,410
-13,610
-7,252
-12,156
Reconciled Depreciation
10.4
10.4
9.868
10.4
10.4
Net Income from Continuing Operation Net Minority Interest
-11,414
-98,298
-14,048
-8,084
-12,683
Total Unusual Items Excluding Goodwill
-408.4
-93,333
-607.001
441.581
-333.658
Total Unusual Items
-408.4
-93,333
-607.001
441.581
-333.658
Normalized EBITDA
-10,413
78,923
-13,003
-7,694
-11,823
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
-8,213
0
0
0